Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
June 24, 1999
Beta2-agonist abuse in food producing animals: use of in vitro liver preparations to assess biotransformation and potential target residues for surveillance
M J Sauer, M Dave, B G Lake, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 1996
The aliphatic oxidation of salmeterol to alpha-hydroxysalmeterol in human liver microsomes is catalyzed by CYP3A
G R Manchee, P J Eddershaw, L E Ranshaw, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1993
Disposition of salmeterol xinafoate in laboratory animals and humans
G R Manchee, A Barrow, S Kulkarni, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
September 1, 1996
Absorption and disposition of ranitidine hydrochloride in rat and dog
P J Eddershaw, A P Chadwick, D M Higton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 14, 2007
A comparison of the expression and metabolizing activities of phase I and II enzymes in freshly isolated human lung parenchymal cells and cryopreserved human hepatocytes
G I Somers, N Lindsay, B M Lowdon, et al.
British Journal of Pharmacology
|
August 1, 1992
GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity
H Rogers, P J Birch, S M Harrison, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 1, 1995
Microbial biotransformation of the angiotensin II antagonist GR117289 by Streptomyces rimosus to identify a mammalian metabolite
R J Cannell, A R Knaggs, M J Dawson, et al.
The Journal of Biological Chemistry
|
December 23, 1999
X-ray crystal structure of human dopamine sulfotransferase, SULT1A3. Molecular modeling and quantitative structure-activity relationship analysis demonstrate a molecular basis for sulfotransferase substrate specificity
R Dajani, A Cleasby, M Neu, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 16, 2006
Design and synthesis of orally active pyrrolidin-2-one-based factor Xa inhibitors
Nigel S Watson, David Brown, Matthew Campbell, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
June 24, 1999
Beta2-agonist abuse in food producing animals: use of in vitro liver preparations to assess biotransformation and potential target residues for surveillance
M J Sauer, M Dave, B G Lake, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 1996
The aliphatic oxidation of salmeterol to alpha-hydroxysalmeterol in human liver microsomes is catalyzed by CYP3A
G R Manchee, P J Eddershaw, L E Ranshaw, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1993
Disposition of salmeterol xinafoate in laboratory animals and humans
G R Manchee, A Barrow, S Kulkarni, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
September 1, 1996
Absorption and disposition of ranitidine hydrochloride in rat and dog
P J Eddershaw, A P Chadwick, D M Higton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 14, 2007
A comparison of the expression and metabolizing activities of phase I and II enzymes in freshly isolated human lung parenchymal cells and cryopreserved human hepatocytes
G I Somers, N Lindsay, B M Lowdon, et al.
British Journal of Pharmacology
|
August 1, 1992
GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity
H Rogers, P J Birch, S M Harrison, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 1, 1995
Microbial biotransformation of the angiotensin II antagonist GR117289 by Streptomyces rimosus to identify a mammalian metabolite
R J Cannell, A R Knaggs, M J Dawson, et al.
The Journal of Biological Chemistry
|
December 23, 1999
X-ray crystal structure of human dopamine sulfotransferase, SULT1A3. Molecular modeling and quantitative structure-activity relationship analysis demonstrate a molecular basis for sulfotransferase substrate specificity
R Dajani, A Cleasby, M Neu, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 16, 2006
Design and synthesis of orally active pyrrolidin-2-one-based factor Xa inhibitors
Nigel S Watson, David Brown, Matthew Campbell, et al.
Page
of 2